Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why
The Cigna Group is one of the few companies that have outperformed the AI-fantasy-driven S&P 500 Index by a wide margin. After a 50% return in less than a year and a new all-time high, it's fair to...
The 3 Best Healthcare Stocks to Buy in April 2024
The recent uptick in U.S. manufacturing signals a promising trend for the economy. Investor confidence in the economy's stability is reflected in the decreasing odds for a June rate cut, indicating...
Health care stocks headed for worst day since early November
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
Cigna (CI) Surpasses Market Returns: Some Facts Worth Knowing
Cigna (CI) reachead $363.34 at the closing of the latest trading day, reflecting a +1.57% change compared to its last close.
Brokers Suggest Investing in Cigna Group (CI): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) an...
S&P 500 Achieves a New Milestone: Top 5 Non-Tech Picks
We have narrowed our search to five non-tech S&P 500 stocks that have provided double-digit returns year to date. These are: CI, RL, PH, ETN, EBAY.
CI or HUM: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - HMOs sector might want to consider either Cigna (CI) or Humana (HUM). But which of these two stocks offers value investors a better bang for their buck...
Cigna Group (CI) Soars to 52-Week High, Time to Cash Out?
Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Cigna Group (CI) Presents at Barclays 26th Annual Global Healthcare Conference Transcript
The Cigna Group (CI) Presents at Barclays 26th Annual Global Healthcare Conference Transcript
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, value enhancing initiatives and a positive 2024 outlook poise it well for growth.
Cigna (CI) Unveils Updated Long-Term Growth Targets & Solutions
Cigna (CI) currently estimates long-term average annual adjusted EPS growth within 10-14%. It also came up with new solutions to better manage the rising GLP-1 costs and expand behavioral care.
Cigna CEO on medicare advantage and GLP-1 access program
Cigna CEO David Cordani joins 'The Exchange' with CNBC's Bertha Coombs to discuss the company's growth opportunity in services, Cigna's GLP-1 access program, and more.
Cigna Strikes Deals To Limit Cost of Weight-Loss Drugs
Cigna Group (CI) said it has taken steps to control the cost and increase coverage of diabetes and weight-loss medicines, which have experienced a boom in demand by those looking to shed pounds.
Wall Street Bulls Look Optimistic About Cigna (CI): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) an...
Related Companies